ARUN P KHAZANCHI
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology LAKEWOOD RANCH, FL NPI 1003961236
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology FL ABBVIE INC. All categories
General Payments — all program years on this page
$7,056.67
- Category: General Payments
- Program years: PY2018–2024
- Record count: 387
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,945.83 across 78 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,945.83 | 78 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $530.18 | 27 |
| MERZ NORTH AMERICA, INC. | $498.75 | 7 |
| Lilly USA, LLC | $147.70 | 9 |
| Phathom Pharmaceuticals, Inc. | $126.25 | 4 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $82.72 | 5 |
| PFIZER INC. | $70.94 | 4 |
| BOSTON SCIENTIFIC CORPORATION | $55.70 | 2 |
| QOL Medical, LLC | $53.19 | 2 |
| Ipsen Biopharmaceuticals, Inc | $49.63 | 2 |
| Regeneron Healthcare Solutions, Inc. | $43.79 | 2 |
| Janssen Biotech, Inc. | $38.83 | 2 |
| Madrigal Pharmaceuticals | $33.80 | 1 |
| Celgene Corporation | $32.01 | 2 |
| GENZYME CORPORATION | $30.02 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.93 | 1 |
| Sumitomo Pharma America, Inc. | $24.60 | 1 |
| Endogastric Solutions, Inc | $22.00 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $18.34 | 1 |
| Teleflex LLC | $17.47 | 1 |
| Braintree Laboratories, Inc. | $14.55 | 1 |
| Merck Sharp & Dohme Corporation | $14.22 | 1 |
| Ardelyx, Inc. | $13.21 | 1 |
By program year
Records — PY2024 (78)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.